MAPT and Alzheimer disease: Although a large number of clinical and preclinical studies suggest that ApoE isoforms impact AD pathogenesis by driving Aβ pathology, ApoE4 also impacts neurodegeneration in the context of Tau pathology, independent of Aβ.